{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-040342","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2026-06-03T20:25:12+00:00","discovered_at":"2026-06-03T20:26:01.325349+00:00","generated_at":"2026-06-03T20:51:14.860435+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Strata Critical Medical stockholders elect directors Heyburn and Lauck, ratify Deloitte, approve say-on-pay","bullets":["William A. Heyburn re-elected with 46,050,902 for, 505,421 withhold, 12,687,496 broker non-votes.","Andrew Lauck re-elected with 39,525,159 for, 7,031,164 withhold, 12,687,496 broker non-votes.","Ratification of Deloitte & Touche as auditor: 58,946,832 for, 65,815 against, 231,172 abstain.","Advisory say-on-pay approved: 38,497,962 for, 8,022,682 against, 35,679 abstain, 12,687,496 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-040342","json":"https://secwatch.observer/filing/0001628280-26-040342.json","markdown":"https://secwatch.observer/filing/0001628280-26-040342.md","text":"https://secwatch.observer/filing/0001628280-26-040342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/0001628280-26-040342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/blde-20260528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T20:51:14.860435+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b27eef02708b9b127bb0ba3288920d9f31d64fa","claim":"Strata Critical Medical, Inc. shareholders approved Election of two Class II directors to hold office until the 2029 annual meeting at the 2026-05-28 meeting.","evidence_excerpt":"For Withhold Broker Non-Votes William A. Heyburn 46,050,902 505,421 12,687,496 Andrew Lauck 39,525,159 7,031,164 12,687,496","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/0001628280-26-040342-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-28"}],"fact_type":"shareholder_vote"},{"claim_id":"926cdde1c8adb13731311683fcfd3af6d844f56e","claim":"Strata Critical Medical, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2026-05-28 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 38,497,962 8,022,682 35,679 12,687,496","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/0001628280-26-040342-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-28"}],"fact_type":"shareholder_vote"},{"claim_id":"a30461b85bddb161cc273a6667091dba5ca3ce0e","claim":"Strata Critical Medical, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.","evidence_excerpt":"For Against Abstain 58,946,832 65,815 231,172","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/0001628280-26-040342-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-28"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}